Transmural Healing and Disease-Modifying Effect of Guselkumab in Crohn's Disease Patients
Status:
RECRUITING
Trial end date:
2028-03-26
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the efficacy of guselkumab in healing of all layers of the digestive tract (transmural healing) with the help of a score called Magnetic Resonance Index of Activity (MaRIA) based on a scan at Week 48.